Contemporary management of peripheral arterial disease: I. Cardiovascular risk-factor modification

Heather L. Gornik, MD, MHS
Sections of Vascular Medicine and Clinical Cardiology, Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, OH

Mark A. Creager, MD
Department of Medicine, Cardiovascular Division, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA

Correspondence: Heather L. Gornik, MD, MHS, Sections of Vascular Medicine and Clinical Cardiology, Department of Cardiovascular Medicine, Cleveland Clinic, 9500 Euclid Avenue, S60, Cleveland, OH 44195; gornikh@ccf.org

Dr. Gornik reported that she has received research grant support from Pfizer.

Dr. Creager reported that he has received consulting fees from Genzyme, Sigma Tau, Vasogen, and Wyeth, and has received consulting fees as well as honoraria for teaching and speaking from the Bristol-Myers Squibb/Sanofi Pharmaceuticals Partnership.

Heather L. Gornik, MD, MHS
Sections of Vascular Medicine and Clinical Cardiology, Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, OH

Mark A. Creager, MD
Department of Medicine, Cardiovascular Division, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA

Correspondence: Heather L. Gornik, MD, MHS, Sections of Vascular Medicine and Clinical Cardiology, Department of Cardiovascular Medicine, Cleveland Clinic, 9500 Euclid Avenue, S60, Cleveland, OH 44195; gornikh@ccf.org

Dr. Gornik reported that she has received research grant support from Pfizer.

Dr. Creager reported that he has received consulting fees from Genzyme, Sigma Tau, Vasogen, and Wyeth, and has received consulting fees as well as honoraria for teaching and speaking from the Bristol-Myers Squibb/Sanofi Pharmaceuticals Partnership.

Heather L. Gornik, MD, MHS
Sections of Vascular Medicine and Clinical Cardiology, Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, OH

Mark A. Creager, MD
Department of Medicine, Cardiovascular Division, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA

Correspondence: Heather L. Gornik, MD, MHS, Sections of Vascular Medicine and Clinical Cardiology, Department of Cardiovascular Medicine, Cleveland Clinic, 9500 Euclid Avenue, S60, Cleveland, OH 44195; gornikh@ccf.org

Dr. Gornik reported that she has received research grant support from Pfizer.

Dr. Creager reported that he has received consulting fees from Genzyme, Sigma Tau, Vasogen, and Wyeth, and has received consulting fees as well as honoraria for teaching and speaking from the Bristol-Myers Squibb/Sanofi Pharmaceuticals Partnership.